Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Advances in Respiratory Disease"
DOI: 10.1177/1753466621998245
Abstract: Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). Advanced particle engineering… read more here.
Keywords: nrf2 activator; microscopy; activator rhoa; spectroscopy ... See more keywords